Q2 2024 Holdings
Filed 2024-08-14 | 433 holdings | $6.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Universal Stainless & Alloy | COM | 913837100 | $1.8M | 65,060 | 0.0% |
| Lowes COS Inc(LOW) | COM | 548661107 | $1.8M | 8,113 | 0.0% |
| Biomx Inc | COM | 09090D103 | $2.1M | 6,110,098 | 0.0% |
| Jabil Inc(JBL) | COM | 466313103 | $2.1M | 19,662 | 0.0% |
| Darden Restaurants Inc(DRI) | COM | 237194105 | $2.2M | 14,344 | 0.0% |
| Quaker Houghton(KWR) | COM | 747316107 | $2.2M | 13,015 | 0.0% |
| Aerovate Therapeutics Inc | COM | 008064107 | $2.3M | 1,411,608 | 0.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $2.9M | 583,913 | 0.0% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $3.5M | 464,252 | 0.1% |
| Fractyl Health Inc(GUTS) | COM | 35168W103 | $3.6M | 834,254 | 0.1% |
| Calcimedica Inc(CALC) | COM NEW | 38942Q202 | $4.0M | 1,000,000 | 0.1% |
| Phreesia Inc(PHR) | COM | 71944F106 | $4.1M | 192,347 | 0.1% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $4.6M | 896,960 | 0.1% |
| Alector Inc(ALEC) | COM | 014442107 | $5.2M | 1,148,326 | 0.1% |
| Neogenomics Inc | NOTE 1.250% 5/0 | 64049MAA8 | $6.3M | $6,500,000 | 0.1% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $7.6M | 877,790 | 0.1% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $9.9M | 1,743,398 | 0.2% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $10.7M | 723,000 | 0.2% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $11.6M | 597,000 | 0.2% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $11.7M | 3,555,871 | 0.2% |
| Accolade Inc(ACCDEUR) | COM | 00437E102 | $12.4M | 3,475,000 | 0.2% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $12.7M | 3,639,000 | 0.2% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $12.9M | 329,000 | 0.2% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $13.2M | 1,540,000 | 0.2% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $13.5M | 5,829,570 | 0.2% |
| CG Oncology Inc(CGON) | COM | 156944100 | $13.7M | 433,540 | 0.2% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $14.5M | 2,518,500 | 0.2% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $14.9M | 1,983,000 | 0.2% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $15.7M | 4,133,000 | 0.3% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $16.7M | 869,250 | 0.3% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $19.0M | 874,609 | 0.3% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $19.3M | 240,218 | 0.3% |
| Pacs Group Inc(PACS) | COM SHS | 69380Q107 | $19.6M | 663,851 | 0.3% |
| Inmode LTD(INMD) | SHS | M5425M103 | $21.3M | 1,166,704 | 0.4% |
| Docgo Inc(DCGO) | COM | 256086109 | $22.2M | 7,195,956 | 0.4% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $22.5M | 3,799,143 | 0.4% |
| Insulet Corp(PODD) | COM | 45784P101 | $22.7M | 112,433 | 0.4% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $24.2M | 6,710,429 | 0.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $26.3M | 1,397,279 | 0.4% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $28.1M | 2,817,763 | 0.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $29.1M | 119,800 | 0.5% |
| Lantheus Hldgs Inc | NOTE 2.625%12/1 | 516544AB9 | $31.5M | $25,255,000 | 0.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $31.6M | 3,744,263 | 0.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $33.2M | 844,407 | 0.6% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $34.1M | 2,726,135 | 0.6% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $35.0M | 1,411,000 | 0.6% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $40.3M | 2,923,137 | 0.7% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $41.4M | 151,714 | 0.7% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $42.8M | 1,467,632 | 0.7% |
| Conmed Corp(CNMD) | COM | 207410101 | $43.8M | 631,264 | 0.7% |